Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
58 studies found for:    SCHIZOPHRENIA 12
Show Display Options
Rank Status Study
1 Recruiting A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia
Condition: Schizophrenia
Interventions: Drug: folate with B12;   Drug: placebo
2 Not yet recruiting Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Dietary Supplement: folic acid 5 mg/cap;   Other: Placebo
3 Completed A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.
Condition: Schizophrenia
Interventions: Drug: BI 409306 100 mg QD;   Drug: BI 498306 50 mg QD;   Drug: Placebo;   Drug: BI 498306 25 mg QD;   Drug: BI 409306 10 mg QD
4 Terminated 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
Condition: Schizophrenia
Intervention: Drug: ziprazidone
5 Completed The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
Condition: Schizophrenia
Interventions: Procedure: Blood sampling;   Drug: Clozapine
6 Completed A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville
Condition: Schizophrenia
Intervention: Drug: Paliperidone ER
7 Completed
Has Results
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
Condition: Schizophrenia
Interventions: Dietary Supplement: Folic Acid;   Dietary Supplement: B12;   Other: Placebo
8 Completed
Has Results
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Aripiprazole IM Depot;   Drug: Placebo
9 Completed A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
Condition: Schizophrenia
Interventions: Drug: AQW051;   Drug: Placebo
10 Completed Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Seroquel SR
11 Completed A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: MP-214 low dose;   Drug: MP-214 middle dose;   Drug: MP-214 high dose
12 Completed Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Sertindole;   Drug: Olanzapine
13 Completed Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Sertindole;   Drug: Olanzapine
14 Completed
Has Results
Switching to Iloperidone From Other Antipsychotics in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: iloperidone
15 Terminated
Has Results
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: PF-02545920;   Drug: Placebo
16 Completed Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate
Condition: Schizophrenia
Intervention:
17 Recruiting Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Condition: Schizophrenia
Interventions: Other: Caregiver psycho-education and skills training;   Other: Caregiver support available at the study site;   Drug: Paliperidone palmitate;   Drug: Chlorpromazine;   Drug: Droperidol;   Drug: Fluphenazine;   Drug: Haloperidol;   Drug: Loxapine;   Drug: Perphenazine;   Drug: Pimozide;   Drug: Prochlorperazine;   Drug: Thiothixene;   Drug: Thioridazine;   Drug: Trifluoperazine;   Drug: Aripiprazole;   Drug: Asenapine;   Drug: Clozapine;   Drug: Iloperidone;   Drug: Olanzapine;   Drug: Paliperidone;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Ziprasidone
18 Completed Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders
Condition: Schizophrenia
Intervention: Behavioral: Assertive Community Treatment (ACT)
19 Completed Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: AZD3480
20 Completed Efficacy of Lu 31-130 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Zicronapine;   Drug: Olanzapine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.